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Background: There are few studies on predictors of smoking cessation in general populations. We studied the
smoking cessation rate in relation to several potential predictors, with special focus on respiratory and cardi-
ovascular disease.
Methods: Smokers (n = 4636) from seven centres in Northern Europe, born between 1945 and 1973, who
answered a questionnaire in 1999–2001 (the RHINE study) were followed up with a new questionnaire in
2010–2012. Altogether 2564 answered the questionnaire and provided complete data on smoking. Cox re-
gression analyses were performed to calculate hazard ratios (HRs).
Results: A total of 999 subjects (39%) stopped smoking during the study period. The smoking cessation rate was
44.9/1000 person-years. Smoking cessation was more common with increasing age, higher education and fewer
years of smoking. Asthma, wheeze, hay fever, chronic bronchitis, diabetes and hypertension did not signiﬁcantly
predict smoking cessation, but smokers hospitalized for ischaemic heart disease during the study period were
more prone to stopping smoking (HR 3.75 [2.62–5.37]).
Conclusions: Successful smoking cessation is common in middle-aged smokers, and is associated with few
smoking years and higher education. A diagnosis of respiratory disease does not appear to motivate people to
quit smoking, nor do known cardiovascular risk factors; however, an acute episode of ischaemic heart disease
encouraged smoking cessation in our study population.
1. Introduction
Tobacco smoking is a leading risk factor for global burden of disease
[1], and on average smokers can expect a considerably shorter life
compared with non-smokers. However, smoking cessation will gradu-
ally reverse the health risks associated with smoking, especially in
younger individuals [2].
The global smoking prevalence has decreased during the last few
decades [3], and in many Northern Europe countries the decline has
been noticeable [3–5]. Nevertheless, smoking still has an immense
impact on general health in these countries.
Smoking cessation interventions importantly contribute to the
struggle against the smoking epidemic. Many smokers make several
attempts to quit, but commonly fail to stay abstinent [6]. Therefore, it is
important to ﬁnd factors that are signiﬁcant in predicting success of
smoking cessation, as can be identiﬁed in prospective longitudinal
studies.
Most studies of predictors of smoking cessation have been per-
formed as intervention trials in smokers seeking help for their addic-
tion, and not in general populations. The smoking cessation issue is
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complex and depends on individual factors as well as factors that are
prevalent in the society where the smoker lives. Smoking cessation
studies in the general population are important as they give a total
overview of quitters, both those that have been seeking professional
help to quit and those who have managed to stop on their own. A re-
latively recent systematic review of prospective, non-interventional
studies on predictors of smoking cessation in adult general populations
found large methodological heterogeneity between the eight included
studies [7]. The only consistent ﬁnding was a negative association be-
tween success of quit attempts and signs of dependency to nicotine.
Motivational factors and a past quit attempt were predictive for making
quit attempts, but not for their success. In separate prospective studies
not included in the systematic review, older age, male gender, higher
socioeconomic status, lower alcohol intake, impaired lung function, a
strong desire to quit smoking, lower nicotine dependence, and no other
smokers in the household have been reported to predict smoking ces-
sation in the general population [8–15]. Apart from impaired lung
function, it seems reasonable to assume that individuals with known
respiratory disease or cardiovascular risk factors/disease would be
more concerned about their health and would therefore be more eager
to stop smoking. The few available data are not consistent
[9–12,15,16], but they do seem to concur that having an acute cardi-
ovascular event encourages smoking cessation [9,16]. In addition, most
previous incidence studies have not used incidence rates based on
person-years, which means that the distribution of smoking cessation
during the study period has not been investigated and that the actual
time “at risk” for smoking cessation has not been taken into account.
These factors, taken together, suggest a need for prospective, gen-
eral population studies in smokers to identify predictors for successful
smoking cessation. Determinants of smoking cessation have been stu-
died in the 1999–2001 follow-up of the European Community
Respiratory Health Survey (ECRHS) II [13]. However, in that study the
predictive value of respiratory disease, heart disease or cardiovascular
risk factors for smoking cessation was not investigated. Two follow-ups,
in 1999–2001 and in 2010–2012, have been conducted in ECRHS
participants from Estonia and the Nordic countries Denmark, Iceland,
Norway and Sweden in a study called the Respiratory Health in
Northern Europe (RHINE) study. The aim of the current study was to
investigate the smoking cessation rate among smokers in the RHINE
general population sample between these two follow-ups in relation to
potential predictors identiﬁed in the literature, with special focus on
respiratory and cardiovascular disease.
2. Materials and methods
The RHINE study is a large prospective, questionnaire-based cohort
study, with participants from Bergen (Norway), Umeå, Uppsala and
Gothenburg (Sweden), Reykjavik (Iceland), Aarhus (Denmark) and
Tartu (Estonia) born between 1945 and 1973. The study was initiated
in 1989–1994, and follow-ups were conducted in 1999–2001 and
2010–2012 [17–19]. In the ﬁrst survey, smoking was not asked for in
all study centres. However, the questionnaire in 1999–2001 comprised
items about smoking history, respiratory diseases and symptoms, al-
lergy, weight, height, hypertension, diabetes and heart disease. Among
the 15,839 individuals providing complete data on smoking, 4636 re-
ported that they were current smokers, by answering “yes” to the
question “Are you a smoker (answer in the aﬃrmative even if you
smoke just a single cigarette, cigar or pipe per week)?”
A new questionnaire was distributed in 2010–2012 and 3114 (67%)
of those who had been smoking in 1999–2001 answered the ques-
tionnaire. Those who did not answer whether they were a smoker or not
(n = 265), who failed to give the year of smoking cessation (n = 132),
or who answered that they had quit before the study period (n = 153)
were excluded. The remaining 2564 were included in the study. Local
ethics committees approved the study and all participants consented to
participate. Smoking cessation at follow-up, i.e. in the 2010–2012
questionnaire, was deﬁned as a negative answer to the above quoted
question on smoking. Year of smoking cessation was derived from the
participants' answers to “If you are an ex-smoker, how old were you
when you stopped smoking?”
The 1999–2001 questionnaire included a question about years of
smoking as well as a question about number of cigarettes, cigars or
packages of pipe tobacco smoked every week. One cigar was assumed to
be equivalent to ﬁve cigarettes and pipe tobacco was converted to
equivalence by weight [20]. Presence of hypertension, or heart disease,
diabetes, wheeze, asthma, and hay fever at baseline (1999–2001) were
inferred from positive answers to “Do you have hypertension?”, “Do
you have heart disease?”, “Has any physician told you that you have
diabetes?”, “Have you had whistling or wheezing in your chest at any
time during the past 12 months?”, “Do you have or have you ever had
asthma?” and “Do you have hay fever or any other allergic rhinitis?”
Chronic bronchitis was deﬁned as chronic productive cough at least
3 months a year for 2 consecutive years [21,22]. The diagnosis was
derived from a positive answer to all of the following questions: “Do
you usually cough up phlegm from your chest, or do you have phlegm
in your chest that is diﬃcult to bring up?”, “Do you bring up phlegm
like this on most days for at least 3 months each year?” and “Have you
had such periods during at least 2 consecutive years?” [23]. Body mass
index (BMI) was calculated from reported weight and height in the
1999–2001 questionnaire using the formula BMI = mass (kg)/(height
(m))2. Educational level was derived from the answer to “What is your
highest level of education?” (less than high school, high school or si-
milar, and university or similar). Parental smoking was derived from
the answer to the question “Did your mother/father ever smoke reg-
ularly when you were a child?” in the 2010–2012 questionnaire.
In the 2010–2012 questionnaire, the same questions about asthma,
chronic bronchitis, and diabetes were asked as in the 1999–2001
questionnaire. In addition, the following questions were asked: “Have
you ever had hypertension diagnosed by a doctor?”, “Have you ever
been treated in hospital for myocardial infarction or angina pectoris?”
and “Have you ever had a stroke?” Subjects answering “yes” to any of
the questions were also asked to report the year of diagnosis/the event.
These questions were used to investigate whether the smoking cessation
rate was higher in those relatively recently diagnosed with a disease.
The SAS statistical package, version 9.4 (SAS Institute, Cary, NC,
USA), was used for most of the analyses. For the incidence rate ana-
lyses, STATA (College Station, TX, USA) was used. The smoking ces-
sation rate (number of new smoking cessation cases/1000 person-years)
with 95% conﬁdence interval (CI) was calculated for the study period
(from 1999–2001 to 2010–2012). Subjects ceased to contribute person-
years after smoking cessation. Cox regression analyses (PROC PHREG)
were used to calculate hazard ratios (HRs). Separate analyses were
performed for men and women. The eﬀect of developing asthma,
chronic bronchitis, diabetes, hypertension, stroke, or angina pectoris/
myocardial infarction during the study period was analysed by separate
Cox models including a time dependent variable for the diagnosis.
Mutual adjustments for all potential risk factors were made.
3. Results
The characteristics of the study participants are shown in Table 1.
Among the 2564 smokers, 999 (cumulative incidence 39%) reported
that they had stopped smoking during the study period (from
1999–2001 until 2010–2012) and stayed abstinent. Reported smoking
cessation time points were relatively evenly distributed over the study
period and the smoking cessation rate for each year during the study
period is shown in Fig. 1. The crude smoking cessation rate over the
whole study period was 44.9/1000 person-years and was lower in re-
lation to chronic bronchitis, presence of wheeze,> 20 years of
smoking, smoking> 140 cigarettes per week and low education in the
univariate analyses (Table 2). Age, gender, BMI ≥ 30, diabetes, hy-
pertension, heart disease, hay fever, asthma, and parental smoking
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during childhood did not seem to signiﬁcantly aﬀect the smoking ces-
sation rate (Table 2).
Results from Cox regression models are presented in Table 3. Higher
age, higher education and few smoking years were factors that pre-
dicted smoking cessation. There was some heterogeneity associated
with centre, with participants from Tartu, Estonia, being less likely to
have stopped smoking.
Stratiﬁcation for gender revealed that higher age predicted smoking
cessation only in women (Table 3). In addition, higher BMI seemed to
predict smoking cessation in men but not in women. Also, men with
chronic bronchitis at baseline were less likely to quit smoking during
the study period compared with those without chronic bronchitis
(Table 3).
Those developing asthma (n = 45), chronic bronchitis (n = 78),
diabetes (n = 65) or hypertension (n = 307) during the study period
while still smoking were not more prone to quit smoking (Table 4). The
same was true for smoking subjects having a stroke (n = 28), but
smokers hospitalized for myocardial infarction or angina pectoris
(n = 72) during the study period were more likely to stop smoking
(Table 4). Twenty-nine per cent of those who quit smoking after their
asthma diagnosis did so in the year they were diagnosed. Corresponding
ﬁgures for chronic bronchitis, diabetes, hypertension, stroke, and
myocardial infarction or angina pectoris were 23%, 10%, 43%, 86%,
and 71%, respectively.
4. Discussion
In the current longitudinal study of 2564 middle-aged smokers,
nearly 40% quit smoking during an approximately 10-year study
period. There was an association between fewer smoking years and a
high level of education, and smoking cessation. In addition, men with
higher BMI and older women were more likely to quit smoking. Neither
presence of airway disease nor the known cardiovascular risk factors
hypertension and diabetes seemed to predict smoking cessation. This
was true also for those who developed airway disease, diabetes or hy-
pertension during the study period. Known heart disease at baseline did
not predict smoking cessation, but an acute episode of ischaemic heart
disease during the study period was associated with a fourfold in-
creased chance of smoking cessation. In those with an episode of stroke,
no such association was seen. The majority of those who quit smoking
among individuals with an acute episode of ischaemic heart disease or
stroke did so in close connection with the episode.
We focused on successful smoking cessation. Individuals who de-
clared that they did not smoke at follow-up were requested to give the
year of smoking cessation so that the smoking cessation rate could be
calculated. Smoking cessation time points were reasonably evenly dis-
tributed over the study period, which means that many of the ex-
smokers in our study had a long smoking-free period. Therefore, the
predictors under study can be regarded as predictors for successful
smoking cessation. Our results are similar to those from a study in a
middle-aged Japanese population where 25% of smokers had quit
during a 10-year study period [14]. However, in a nationally re-
presentative sample of US adults, almost 40% tried to quit during a 3-
year study period, but fewer than 5% of those who tried succeeded
[24]. The divergent results of the studies reﬂect the complexity of
smoking behaviour that can be inﬂuenced by a wide variety of factors
Table 1
Demographic characteristics of the study population at baseline in 1999–2001, with
educational data and parental smoking during childhood reported in 2010–2012.
All
(n = 2564)
Ex-smokers at
follow-up
(n = 999)
Smokers at follow-
up
(n = 1565)
Age, years (SD) 40.7 (7.0) 40.4 (7.1) 40.9 (6.9)
Female gender 53.5% 55.5% 52.2%
BMI ≥ 30 8.6% 8.4% 8.8%
Diabetes 1.7% 1.4% 1.9%
Hypertension 6.9% 7.3% 6.7%
Heart disease 2.7% 2.5% 2.7%
Chronic bronchitis 9.8% 8.1% 10.9%
Hay fever 19.9% 20.0% 19.9%
Wheeze 34.0% 30.2% 36.4%
Asthma 8.7% 8.5% 8.9%
Years of smoking (SD) 21.3 (8.3) 19.9 (8.6) 22.1 (8.1)
Cigarettes per week
(SD)
90.2 (82.4) 83.0 (78.8) 94.7 (84.4)
Parental smoking 74.8% 74.0% 75.3%
Less than high school 16.9% 13.3% 19.3%
High school or similar 49.0% 46.7% 50.5%
University or similar 34.0% 40.0% 30.2%
BMI = body mass index; SD = standard deviation.
Fig. 1. Smoking cessation rate (number of new smoking
cessation cases/1000 person-years) each year during the
study period.
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[16].
Data for the Nordic countries Denmark, Iceland, Norway and
Sweden show that the smoking prevalence has decreased substantially
during the last few decades [3–5]. In part, this is probably an eﬀect of
an increased smoking cessation rate and is therefore in line with the
results of the current study. By contrast, in Estonia the smoking pre-
valence seems to have been fairly constant since 1980 [3], which may
be reﬂected in the lower smoking cessation rate among the participants
from Tartu.
In the current study, chronic bronchitis did not seem to predict
smoking cessation. On the contrary, men with chronic bronchitis at
baseline were less likely to quit smoking. There are other prospective
studies supporting that chronic bronchitis does not predict smoking
cessation [10,12], and we found the same result for asthma, wheeze,
and hay fever. In addition, asthma and chronic bronchitis, which
started during the study period, were not associated with smoking
cessation. These results are in line with results from a recent study by
Tsai et al., which showed that “respiratory disease” did not predict
smoking cessation [15]. It therefore appears that respiratory symptoms
and known airway disease do not aﬀect the chance of successful
smoking cessation, which is somewhat surprising since many ex-smo-
kers report that health concerns were a major reason why they quit
smoking [25].
Another intriguing ﬁnding in our study was that smokers at baseline
reporting risk factors for cardiovascular disease such as hypertension
and diabetes, and even smokers with heart disease did not seem to have
an increased rate of successful smoking cessation. However, subjects
reporting an acute episode of ischaemic heart disease during the study
period were more prone to quit smoking. In these latter subjects, and in
individuals with stroke, the vast majority chose to quit smoking in the
same year as the event occurred, and very few stopped at a later time
point. This pattern was not seen in those diagnosed with hypertension,
diabetes, or respiratory disease, during the study period, and they did
not show a signiﬁcantly higher smoking cessation rate. Probably the
majority of these individuals were diagnosed in connection with a
health care visit. In that case, this visit probably did not aﬀect their
smoking behaviour, which is a poor reﬂection of the health care system.
There are few other prospective studies in general populations on this
question, but a study in middle-aged Taiwanese male smokers showed
similar results to ours [15]. The authors of the Taiwanese study found
that a ﬁrst emergency visit or development of coronary heart disease,
but not a new diagnosis of hypertension or diabetes, predict smoking
cessation. In a Danish longitudinal study, reported angina pectoris did
not predict smoking cessation [10]; by contrast, data from the Fra-
mingham Heart Study show that development of heart disease predicts
smoking cessation within the following 2 years [9].
In the current study, higher BMI was predictive of smoking cessa-
tion, but only in men. Overweight has been shown to predict smoking
cessation in women and it has been suggested that subjects with higher
BMI are less concerned about weight gain associated with quit attempts
[11,12]. On the other hand, data from the ECRHS II indicate that
overweight women are less likely to quit smoking [13].
High social status and education have been shown to predict
smoking cessation [10,13], but there are contradictory data [7,15]. In
the current study, we found a strong association between educational
level and smoking cessation, based on reported educational level at
follow-up.
In our study, higher age was a signiﬁcant but fairly weak predictor
for smoking cessation, which is in agreement with several other studies
[8–10,12,15]. However, in a recent systematic review, age did not seem
to consistently predict quit attempt success [7]. In most cases, smoking
starts early in life and it may be argued that older smokers have smoked
for a longer time and are, therefore, more addicted. It has been con-
vincingly shown that a lower level of nicotine dependence predicts
smoking cessation [7–12,15] and in our study we found that those with
few smoking years were more prone to quit. In fact, the eﬀect of age
was revealed after we had made adjustments for number of smoking
years and number of cigarettes smoked per week.
In a general review, it has been claimed that women compared with
men are less likely to succeed in quitting smoking [26]. However, no
gender diﬀerences were found in the systematic review by Vangeli et al.
[7], which is in agreement with our study. A recent review found large
variations in sex/gender diﬀerences in smoking cessation between
prospective observational studies. The authors suggested that this could
be attributed to bio-psycho-social variation in samples over time and
location [27].
The present study has several strengths but it also has limitations.
When using self-reported data, recall bias is a threat to the validity of a
study. However, the prospective design of the major part of this study
reduces this potential hazard. In observational studies there is also a
possible risk of misclassiﬁcation, and we did not validate the self-re-
ported smoking status with any biochemical marker. The incidence rate
of smoking cessation could be over-estimated as many individuals do
not want to deﬁne themselves as smokers. However, most participants
who reported that they had stopped smoking described a long period of
Table 2
Smoking cessation rates (cases/1000 person-years) and crude relative risks for smoking
cessation in relation to age, gender, body mass index (BMI), diabetes, hypertension, heart
disease, chronic bronchitis, hay fever, wheeze, asthma, and smoking history at baseline in
1999–2001, and to educational level in 2010–2012.
Smoking cessation rate
(95% conﬁdence
interval)
Smoking cessation rate
ratio
(95% conﬁdence interval)
All n=2564 44.9 (42.1–47.7)
>40 years old
Yes 42.8 (39.3–46.6) 0.90 (0.79–1.02)
No 47.5 (43.3–52.0)
Woman
Yes 47.0 (43.2–51.1) 1.11 (0.98–1.26)
No 42.4 (38.6–46.6)
BMI ≥30
Yes 42.5 (33.9–52.7) 0.94 (0.74–1.17)
No 45.4 (42.5–48.5)
Diabetes
Yes 32.1 (17.6–53.9) 0.71 (0.39–1.20)
No 45.1 (42.3–48.0)
Hypertension
Yes 45.6 (35.8–57.4) 1.02 (0.79–1.29)
No 44.8 (42.0–47.8)
Heart disease
Yes 38.1 (24.6–56.2) 0.82 (0.52–1.21)
No 45.1 (42.3–48.0)
Chronic bronchitis
Yes 35.2 (28.0–43.8) 0.77 (0.60–0.96)
No 46.0 (43.0–49.0)
Hay fever
Yes 45.6 (39.5–52.3) 0.98 (0.84–1.15)
No 44.7 (41.6–47.9)
Wheeze
Yes 38.6 (34.4–43.2) 0.80 (0.70–0.92)
No 48.2 (44.7–51.9)
Asthma
Yes 44.4 (35.5–54.9) 0.99 (0.78–1.24)
No 44.9 (42.0–47.9)
>20 years of smoking
Yes 39.0 (35.8–42.4) 0.71 (0.63–0.81)
No 54.8 (49.8–60.2)
>140 cigarettes per week
Yes 36.5 (31.3–42.4) 0.78 (0.66–0.92)
No 46.8 (43.4–50.3)
Parental smoking
Yes 44.4 (41.2–47.7) 0.96 (0.83–1.11)
No 46.3 (40.8–52.3)
Educational level
University or similar 56.2 (50.8–62.0) 1.70 (1.39–2.08)
High school or similar 41.8 (38.1–45.8) 1.26 (1.04–1.55)
Less than high school 33.1 (27.7–39.2)
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abstinence, which probably decreased the risk of “false” smoking ces-
sation, and data from reviews and separate studies not included in the
reviews indicate that self-reports of smoking are fairly accurate
[28–34]. In our study, individuals who reported that they had quit
smoking, but did not give the year of smoking cessation, or who an-
swered that they had quit before the study period were excluded. This
will, of course, have resulted in a somewhat lower smoking cessation
rate than if a correct year had been given by all participants.
A long period of follow-up, the relatively large sample size, and a
fairly high response rate are all strengths of this study. Even though
little is known about selection bias at baseline, predictors of long-term
participation have been thoroughly investigated in the RHINE cohort
[19]. In the cohort, female sex and increasing age were both predictors
for long-term participation; also, respiratory symptoms, except rhinitis,
were somewhat underestimated among long-term participants [19].
However, exposure-outcome associations seemed largely unaﬀected by
loss to follow-up [19]. Taken together, we consider the results of the
current study to be generalizable.
5. Conclusions
It is encouraging that a large proportion of middle-aged smokers
seemed to be able to successfully quit smoking. We saw an association
between few smoking years and smoking cessation, and also between
higher education and smoking cessation. Higher BMI was predictive of
smoking cessation in men but not in women. In addition, an acute
ischaemic heart disease event seemed to be a strong predictor for
smoking cessation. On the other hand, respiratory disease or known
cardiovascular risk factors did not appear to discourage individuals
from smoking, even those recently diagnosed. In the meeting with
smoking patients, health care staﬀ need to be more active and engaged
in assisting those with respiratory disease and cardiovascular risk fac-
tors to quit smoking.
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